Vaxart, Inc. SEC filings VXRT

Vaxart, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to May 18, 2011. Its latest annual report, Form ARS, was filed on Jun 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
10-Q Quarterly report May 9, 2022 Mar 31, 2022
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
10-Q Quarterly report May 12, 2020 Mar 31, 2020
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
10-Q Quarterly report Aug 8, 2019 Jun 30, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
10-Q Quarterly report Nov 13, 2018 Sep 30, 2018
10-Q Quarterly report Aug 10, 2018 Jun 30, 2018
10-Q Quarterly report May 15, 2018 Mar 31, 2018
10-Q Quarterly report Feb 6, 2018 Dec 31, 2017
10-Q Quarterly report Nov 7, 2017 Sep 30, 2017
10-Q Quarterly report May 8, 2017 May 2, 2017
10-Q Quarterly report Feb 6, 2017 Dec 31, 2016
10-Q Quarterly report Nov 8, 2016 Sep 30, 2016
10-Q Quarterly report May 10, 2016 Mar 31, 2016
10-Q Quarterly report Feb 8, 2016 Dec 31, 2015
10-Q Quarterly report Nov 6, 2015 Sep 30, 2015
10-Q Quarterly report May 8, 2015 Mar 31, 2015
10-Q Quarterly report Feb 6, 2015 Dec 31, 2014
10-Q Quarterly report Nov 7, 2014 Sep 30, 2014
10-Q/A Amended quarterly report Jun 19, 2014 Mar 31, 2014
10-Q Quarterly report May 12, 2014 Mar 31, 2014
10-Q Quarterly report Feb 10, 2014 Dec 31, 2013
10-Q Quarterly report Nov 12, 2013 Sep 30, 2013
10-Q Quarterly report May 10, 2013 Mar 31, 2013
10-Q Quarterly report Feb 11, 2013 Dec 31, 2012
10-Q Quarterly report Nov 8, 2012 Sep 30, 2012
10-Q Quarterly report Aug 9, 2012 Jun 30, 2012
10-Q Quarterly report May 10, 2012 Mar 31, 2012
10-Q Quarterly report Nov 2, 2011 Sep 24, 2011
10-Q Quarterly report Aug 3, 2011 Jun 25, 2011

Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VXRT (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
72444
Former names
Aviragen Therapeutics, Inc. (until Feb 15, 2018); Biota Pharmaceuticals, Inc. (until Apr 13, 2016); NABI BIOPHARMACEUTICALS (until Nov 8, 2012); NABI BIOPHARMACEUTICALS (until Jun 29, 2010); NABI /DE/ (until Feb 14, 2002)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.